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URTICARIA CAUSED BY
ARCANOBACTERIUM HAEMOLYTICUM. DIAGNOSTIC
AND THERAPEUTIC FAILURES
ABSTRACT: We presented a case of seventeen-year-old girl exhibiting mild symp-
toms of sore throat, a marked urticarial rash and heavy desquamations of the skin on palms
and soles. According to the antibiogram and diagnosis of Streptococcus non A non B group
obtained in routine laboratory procedure, the patient was treated with penicillin; however,
ineffectively. Escalation of urticaria and failure of the initial penicillin therapy shifted the
diagnosis towards exanthema toxoalergicum and thus to treatment with corticosteroids and
antihistamines, yet with no improvement. The culture was repeated with a new specimen.
Diagnosis was made according to the specific pattern in a double CAMP test, and confir-
med by the ApiCoryne diagnostic set (BioMerieux).
With respect to cultural traits, the isolate mimicked Streptococcus pyogenes, yet de-
veloping specific pattern in a double CAMP test that directed our diagnosis towards
coryneform microorganisms. The diagnosis of Arcanobacterium haemolyticum was confir-
med with 99.9% probability rate and T = 0.75.
KEY WORDS: Arcanobacterium haemolyticum, exanthema, diagnosis, erythromycin
therapy
INTRODUCTION
Arcanobacterium haemolyticum (A. haemolyticum) is one of the four spe-
cies of the genus Arcanobacterium [R a m o s, 1977] exhibiting all characteri-
35stics of irregular non-sporulating Gram-positive rods [H o l t, 1994; F u n k e,
1997].
Man is the primary reservoir and the most frequently affected species,
though there are reports of isolates of animal origin [R i c h a r d s o n and
S m i t h, 1968; R o b e r t s, 1969; Y ounan a n d Drescher ,1996; S u -
v a j d ÿ i ã et al., 2002; S u v a j d ÿ i ã et al., 2002]. Young adults are the
most frequently affected population [M i l e r et al., 1986; S l a r r i d g e, 1989;
C a r l s o n et al., 1994; N y m a n and B a n c h, 1984], but there are reports
of infection in children [K a r p a t h i o s et al., 1992]. In immunocompromi-
sed individuals, infections of the upper respiratory tract are mostly induced
[ M a c L e a n et al., 1946; M a c k e n z i e et al., 1995; C h a l u p a et al.,
1995], which may be associated with a rash [B a n c k and N y m a n, 1986]
of the scarlatinoform [C a r l s o n et al., 1994] or urticarial type and enlarged
lymph nodes, particularly in the neck region [B a n c k and N y m a n, 1984].
Clinical symptoms mimicking rash fevers of viral etiology and undefined aller-
gic events often result in overlooking this organism in a suspect diagnosis.
Due to its close similarity to the beta-hemolytic species of the genus Strepto-
coccus and nondescript colonial architecture, it is often misidentified in a rou-
tine practice, though its pathogenic potential is well established as early as
1946 [M a c L e a n et al., 1946].
MATERIAL AND METHODS
Study subject
The patient was a seventeen-year-old girl without personal or family
history of chronic disease or allergy. She was admitted for examination becau-
se of a skin rash in the chest region. The patient was in good general condi-
tion, with slightly increased body temperature (37.3°C) and without any su-
bjective complaints.
Physical examination revealed a light-pink macular rash, circular in sha-
pe, with no skin elevation, with distinct maculae surrounded by unchanged
skin. Signs of mild rhinopharyngitis were evident, as well as a slight enlarge-
ment of a submental lymph node (about 1 cm in diameter). There were no
changes on other organs and organ systems. The presentations were characteri-
zed as Rubella and symptomatic therapy was recommended.
After 2—3 days, changes of rash appearance and distribution became ob-
vious, extending across the body and extremities, being most prominent at the
lower abdomen. Efflorescences were maculopapular, slightly elevated from the
skin level, red, oval, distinct or convergent (particularly on the extremities),
different in size, and with zones of healthy (unchanged) skin amongst them.
Pronounced pruritus was present. Body temperature was slightly increased
(37.3°C), the pharynx was hyperaemic without enanthema, and the submental
lymph node was unchanged with respect to the previous examination.
Laboratory findings showed a slightly increased sedimentation rate, 20
mm/hour. Blood count revealed leucocytosis 15x103/l with prevailing neutro-
36phyles (87%), fibrinogen 4.0. Billirubin, transaminase and gamma GT values
were within the limits of normal ones. Electrophoresis of serum proteins was
not performed due to technical reasons.
Complement fixation test (CFT): Adeno 1/16, Mycoplasma pneumoniae
< 1/4, Chlamydia trachomatis (group Ag) < 1/2, Paul Bunell negative
Enzyme Linked Immunosorbent Assy (ELISA) IgM Rubella negative
Pharyngeal swab: Streptococcus non A non B group
Recommended therapy — Fenoxymethylpenicillin (Cliacil®).
The therapy applied in the first week was ineffective.
The efflorescences gradually resolved over a period of seven days, but
new ones of the same characteristics occurred in other skin areas. Around day
12 after the commencement of the rash, discrete scaling of palms was noted,
progressing to massive desquamation of large epidermal areas within 2—3
days. Palms and soles were extremely painful to palpation.
Skin changes were characterized as exanthema toxoallergicum by the epi-
demiologist and dermatologist. The dermatologist suggested antihistaminic the-
rapy with terfenadine (Bronal®) and corticosteroids (Dexason® tb.). The the-
rapy was administered during the second week of illness, without any impro-
vement with respect to skin changes.
In the third week of illness, the rash gradually diminished and desqua-
mation of palms and soles ended. The overall condition of the patient was
good, except for the malaise and fatigue. The patient was referred by his
physician to the microbiology laboratory of the Department of Pharmacy with
the aim of receiving specific therapy. In that respect, the pharyngeal swab was
repeated, revealing presence of Arcanobacterium haemolyticum. We suggested
a therapy with erythromycin, 500 mg, 2 times per day, during 7 days. The
therapy was administered in the third week of illness. Improvement occurred 2
days following the administration of erythromycin.
MICROBIOLOGICAL METHODS
The pharyngeal swab was simultaneously inoculated with and without
growth lines of Staphylococcus aureus (2 plates of each). Subcultures were
cultivated on two thioglycolate and one nutrient broth. Thioglycolates were in-
cubated at 37 and 44°C, and the nutrient broth was kept in refrigerator at
+4°C. After 48 hours, thioglycolates were subcultured onto three blood agars,
which were incubated aerobically, anaerobically and microaerophilically. The
nutrient broth was incubated at +4°C during 7 days. Subcultures on blood agar
were made daily.
Preparations of primoisolates and subcultures were Gram stained, and the
grown colonies examined in catalase, oxidase and esculin tests. “Double CAMP
test" (Rhodococcus-a ureus CAMP at the same blood agar plate) [4, 18] was
performed, and possibility of bacterial growth in the presence of bile acids
(0.33% cholic and 0.33% monoketocholic acid) was investigated. Ability of
agglutination with streptococcal serums in the commercial Slidex Strepto Bio-
Merieux set (Bio Merieux, Marcy-l'Etoile, France) was also tested. Final diag-
37nosis was performed with the API Coryne (Bio Merieux, Marcy-l'Etoile, Fran-
ce) diagnostic kit, and later evaluated using a software program from the same
manufacturer.
RESULTS
In all incubation and temperature conditions, small hemolytic colonies
grew on blood agar, which strongly resembled beta haemolytic cocci. How-
ever, they did not agglutinate with any of streptococcal diagnostic sera in the
SLIDEX Strepto-kit (BioMerieux, Marcy-l'Etoile, France). Further thorough
investigation of the subcultures revealed Gram-positive rods in young cultures
(up to 18 hours of age), which, with age, changed their morphology towards
pleomorphism and polychromasia. The tendency towards Gram-labile, granula-
ted, irregular coccoid form culminated as early as in 24 hours. Oxydase, cata-
lase and esculin tests were negative. In a double CAMP test the isolate produ-
ced a strong restriction of haemolysis of S. aureus and a marked synergistic
haemolysis with Rhodococcus equi, with a characteristic “open umbrella" sha-
ped pattern (Figures 1, 2 and 3). Biochemical characteristics are summarized
in Table 1.
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Fig. 1 — CAMP phenomenon on day 1 of incubation39
Fig. 2 — CAMP phenomenon on day 2 of incubation
Fig. 3 — CAMP phenomenon on day 3 of incubationNote development of the specific pattern of species-specific A. haemo-
lyticum in a double CAMP test — synergistic haemolysis with Rhodococcus
equi (“open umbrella") and restriction of beta-haemolysis of Staphylococcus
aureus
Key Note:
Right vertical line = Staphylococcus aureus
Left vertical line = Rhodococcus equi
Top and bottom horizontal lines = Streptococcus agalactiae
Two horizontal lines in the middle = Arcanobacterium haemolyticum
Tab. 1 — Biochemical characteristics of the investigated A. haemolyticum strain. Identification ta-
ble of % positive reaction after 24h at 35—37°C
TEST REACTION
ISOLATE REACTION
INVESTIGATED
STRAIN
IDENTIFICATION
TABLE
12
NIT NITrate reduction 0/1 1
PYZ PYraZinamidase 1/1 98
PyrA Pyrolydonil
Arylamidase 0/1 70
PAL Alkaline phosphatase 1/1 85
-GUR Beta glucuronidase 0/1 36
-GAL Beta galactosidase 1/1 89
-GLU Alpha glucosidase 0/1 92
-NAG N-A-Glucosaminidase 1/1 89
ESC Esculin 0/1 0
URE Urea 0/1 0
The result was red using the BioMerieux software program (Bio Merieux,
Marcy-l'Etoile, France), being A. haemolyticum, with the probability rate of
99.9% and T = 0.75. The only parameter that departed from the identification
table was alpha glucosidase negativity, which should have been positive in
92%.
DISCUSSION
A. haemolyticum was isolated in a 17-year-old patient. According to the
results of M iller e ta l .(1986), this organism is mostly isolated in teenagers
and younger adults. This was also confirmed by C l a r r i d g e (1989) and
C a r l s o n et al. (1994).
The organism was isolated from the pharynx, which was confirmed as the
predilection site by several authors [M a c L e a n et al., 1946; M a c k e n z i e,
1995; C h a l u p a et al., 1995].
The rash was the dominant finding, preceding sore throat, rather urticarial
then scarlatinoform, and accompanied by pruritus. Skin scaling followed by
desquamation of palms and soles was obvious. These changes are not typical
for pharyngitis caused by A. haemolyticum [W a g n e r, 1991] but there are se-
veral descriptions in the literature [M a c k e n z i e, 1995; C h a l u p a et al.,
401995; B a n c h, 1986]. The initial report described one of 12 patients with
rash attributed to allergy, diagnosed as exanthema toxoallergicum, same as our
patient [M a c L e a n et al., 1946].
A. haemolyticum was isolated in abundance, without presence of other
potential pathogenic bacterial agents. Streptococcus-like colonies with coryne-
form microscopic appearance were suggestive of Arcanobacterium / Actino-
myces spp. The diagnosis was made according to the characteristic pattern in
the double CAMP test. Haemolysis restriction of S. auerus and synergism with
the equi factor of R. equi is pathognomonic for A. haemolyticum [C l a r i d g e
and S p i e g e l, 1995; S u v a j d ÿ i ã et al., 1998], which was confirmed by
the APICoryne diagnostic set program (Bio Merieux, Marcy-l'Etoile, France).
By the available methodology, viral agents Chlamydia trachomatis and
M. pneumoniae were excluded, thus we believe A. haemolyticum is the causa-
tive agent of the described status. The patient was treated with penicillin that,
in spite of its good activity in vitro, did not result in any improvement. This
result is consistent with reports of Banck, Nyman and Osterlund [B a n c k and
N y m a n, 1986; N y m a n and B a n c h, 1984; O s t e r l u n g, 1995; N y -
m a n and B a n c h, 1990].
CONCLUSION
Prompt etiological diagnosis is of crucial importance for clinicians, pro-
tecting patients and physicians from diagnostic and therapeutic failures (in this
case the patient could have been spared from cortisone and antihistaminic
therapy). In cases of a rash of unclear etiology accompanied by pharyngitis,
we suggest excluding the presence of A. haemolyticum. In the case that the
microbiology laboratory does not have relatively expensive diagnostic sets
(BioMerieux or else), diagnosis can be made at the cost of a single blood agar
Petri-plate, using characteristic pattern in a double CAMP test, which is species-
-specific.
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Rezime
Arcanobacterium haemolyticum se retko izoluje kao uzroånik faringitisa
koji je u 30% sluåajeva praãen egzantemom. U rutinskoj praksi obiåno se previ-
di jer kliniåki imitira alergijski, poststreptokokni ili osip virusne etio-
logije. Prikazujemo sluåaj sedamnaestogodišwe devojke koja je imala blage simp-
tome upale grla praãene naglašenim urtikarijalnim rašom sa poslediånom de-
skvamacijom koÿe stopala i dlanova. Vodeãi se rezultatom antibiograma i bak-
teriološkom dijagnozom Streptococcus nonA nonB grupe pacijent je tretiran pe-
nicilinom ali bezuspešno. Eskalacija urtike nakon uvoðewa penicilina zave-
la je kliniåara ka dijagnozi exanthema toxoalergicum. Stoga je nastavqen tretman
antihistaminicima i kortikosteroidima takoðe bezuspešno. Ponovno uzet bris
je bakteriološki obraðen u ciqu iskquåivawa korineformnih bakterija. Na
osnovu specifiånog rezultata u dvostrukom CAMP testu posumwano je na Arca-
nobacterium haemolyticum, a dijagnoza je potvrðena dijagnostiåkim setom ApiCo-
ryne diagnostic set. Softverski program istog proizvoðaåa dijagnozu Arcanobacte-
rium haemolyticum je ocenio kao odliånu, sa verovatnoãom identiteta 99,9% uz
stepen sigurnosti T = 0.75. Ovakva dijagnoza sugerisala je eritromicinsku te-
rapiju — 500 mg 2 puta dnevno u trajawu od 7 dana što je dovelo do potpunog
izleåewa pacijenta. Shodno tome u sluåajevima raša nejasne etiologije udruÿe-
ne sa faringitisom sugerišemo iskquåivawe Arcanobacterium haemolyticum. Pre-
cizna mikrobiološka dijagnoza dostupna je svakoj rutinskoj laboratoriji uko-
liko se umesto obiånog CAMP testa u sluåaju beta hemolitiåkih kolonija strep-
tokoknog izgleda koristi dvostruki CAMP test.
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